LifeStance Health Group Quarterly Income Statement
NASDAQ: LFSTHealth CareMedical/Nursing ServicesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
LifeStance Health Group revenue and earnings
In the quarter ended Jun 30, 2026, LifeStance Health Group generated $435.4 million in revenue, up 26.1% from the same quarter a year earlier. Net income was $23.6 million, for a net margin of 5.4% versus a median of 0.3% in the prior 5 quarters. Operating margin was 7.0%.
Diluted earnings per share came in at $0.06.
Summary generated from market data by MetaCap's automated system. Methodology
LifeStance Health Group income statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 435.35M | 403.48M | 382.19M | 363.81M | 345.31M | 332.97M | 325.48M | 312.72M | 312.33M | 300.44M | 280.60M | 262.89M |
| Revenue growth (YoY) | +26.08% | +21.17% | +17.43% | +16.34% | +10.56% | +10.83% | +15.99% | +18.95% | +20.32% | +18.94% | +22.34% | +20.84% |
| Operating Expenses | 404.70M | 381.19M | 364.11M | 356.40M | 348.26M | 331.37M | 324.42M | 312.68M | 328.28M | 317.21M | 312.87M | 337.25M |
| Selling, General & Admin | 108.14M | 100.33M | 94.78M | 95.61M | 97.38M | 94.43M | 93.71M | 85.27M | 95.15M | 88.93M | 93.37M | 130.94M |
| Operating Income | 30.65M | 22.28M | 18.08M | 7.41M | -2.95M | 1.60M | 1.06M | 47.00K | -15.95M | -16.77M | -32.27M | -74.36M |
| Interest Expense | 2.63M | 1.79M | 2.88M | 2.81M | 2.90M | 3.07M | 9.40M | 5.41M | 5.82M | 5.90M | 5.53M | 5.48M |
| Other Income (Expense) | -3.20M | -2.52M | -2.88M | -2.84M | -2.99M | -3.07M | -9.94M | -5.43M | -6.67M | -3.96M | -6.04M | -3.61M |
| Pretax Income | 27.46M | 19.76M | 15.20M | 4.57M | -5.94M | -1.47M | -8.88M | -5.38M | -22.62M | -20.73M | -38.32M | -77.97M |
| Income Tax | 3.85M | 5.52M | 3.54M | 3.50M | -2.15M | -2.18M | -1.76M | 575.00K | 656.00K | 363.00K | 6.64M | -16.39M |
| Net Income | 23.61M | 14.24M | 11.67M | 1.08M | -3.79M | 709.00K | -7.11M | 709.00K | -23.28M | -21.10M | -44.96M | -61.58M |
| Net Income growth (YoY) | — | +1908.89% | — | +51.90% | — | — | — | — | — | — | — | — |
| EPS (Basic) | 0.06 | 0.04 | 0.04 | 0.00 | -0.01 | 0.00 | -0.01 | -0.02 | -0.06 | -0.06 | -0.12 | -0.17 |
| EPS (Diluted) | 0.06 | 0.04 | 0.03 | 0.00 | -0.01 | 0.00 | -0.01 | -0.02 | -0.06 | -0.06 | -0.12 | -0.17 |
| Shares Outstanding (Basic) | 383.52M | 387.26M | — | 386.96M | 386.73M | 383.27M | — | 380.36M | 379.43M | 376.33M | — | 372.48M |
| Shares Outstanding (Diluted) | 387.30M | 395.08M | — | 388.89M | 386.73M | 390.67M | — | 380.36M | 379.43M | 376.33M | — | 372.48M |
| EBITDA | 41.96M | 32.65M | 28.43M | 17.75M | 7.69M | 11.89M | 11.18M | 10.46M | -5.82M | -6.75M | -22.60M | -64.91M |
| Operating Margin | 7.04% | 5.52% | 4.73% | 2.04% | -85.00% | 48.00% | 33.00% | 2.00% | -5.11% | -5.58% | -11.50% | -28.28% |
| Net Margin | 5.42% | 3.53% | 3.05% | 30.00% | -110.00% | 21.00% | -2.19% | 23.00% | -7.45% | -7.02% | -16.02% | -23.42% |
This table shows 12 quarterly periods of LifeStance Health Group's income statement, from Q2 2026 back to Q3 2023, across 16 line items including revenue, operating expenses, selling, general & admin. Values in USD; B = billions, M = millions. Fiscal periods follow LFST's reporting calendar. What is a income statement?